Y-12 Interns Major in Summertime Learning

This article features 3 of the 51 CNS interns, who hail from 13 states and 25 colleges. Y‑12 boasts 36 interns, while Pantex hosts 15. With an almost 50/50 split among male and female participants, the majority of interns, 33, are engineering majors, followed by computer science degree seekers.

Latest WalletHub Analysis Places Tennessee at #15 of Best States for Business Starts

Tennessee ranked #15 in WalletHub’s latest analysis of best states in which to start a business. According to the report, the Volunteer State placed #7 in terms of business environment which was weighted at 50 percent of the total points awarded. The other two categories each accounted for 25 percent of the total, and Tennessee placed #16 in terms of business costs, but #39 in access to resources.

ORAU Selected for NIH Path to Excellence Initiative

ORAU recently was selected to participate in the National Institutes of Health 2021 Path to Excellence and Innovation Initiative 2.0 cohort. The new NIH PEI 2.0 cohort is designed to assist in strengthening contracting opportunities for Historically Black Colleges and Universities, while improving collaborations with small businesses.

Y-12’s Zero Power Physics Reactor Depleted Uranium Recovery Project Yields Results

Earlier this year, the National Nuclear Security Administration’s (NNSA) Office of Nuclear Material Integration (ONMI), in cooperation with the Y-12 National Security Complex (Y-12), completed the Zero Power Physics Reactor (ZPPR) Depleted Uranium (DU) Recovery Project. The effort successfully recovered 28 metric tons of high-purity DU blocks previously used in the ZPPR; a research reactor located at the Idaho National Laboratory.

UTRF Develops Agreement Enabling Rapid, Long-term Collaboration with Moderna to Fight COVID-19

At the University of Tennessee Health Science Center in Memphis, UTRF entered into a hybrid agreement with Moderna to leverage technology, expertise and materials from UTHSC. This collaboration allows Moderna to better fight SARS-CoV-2 and evaluate its vaccine against new variants.